Clover Health Investments, Corp. recently reported that its Chief Financial Officer, Joseph Clay Thornton, acquired 328,947 shares of Class A common stock. This acquisition was made through a time-based restricted stock unit (RSU) award, which is a common practice among executives to align their interests with those of shareholders.

The transaction, dated November 4, 2026, is significant as it reflects Thornton's commitment to the company. Following this transaction, Thornton now holds a total of 1,573,882 shares of Clover Health. The filing indicates that twenty-five percent of the RSUs will vest on the first anniversary of the grant date, with the remainder vesting in quarterly installments over the next few years, contingent on Thornton's continued service.

Background

Clover Health Investments, Corp. operates in the hospital and medical service plans sector. The company, incorporated in Delaware, has undergone several name changes since its inception, with its most recent name change occurring on January 7, 2021. Clover Health is publicly traded and has the ticker symbol CLOV.

What the Filing Says

The SEC filing, dated November 6, 2026, details Thornton's acquisition of shares and notes that the transaction is categorized under Form 4. It states, "Represents shares of Class A common stock underlying a time-based restricted stock unit award (RSUs)." The filing confirms that the transaction was executed at no cost per share, which is typical for RSUs.

Impact

This acquisition may have implications for other executives and stakeholders within Clover Health, as it underscores the importance of aligning executive compensation with company performance. It may also influence investor perceptions regarding the company's leadership and future direction. The healthcare sector, particularly in hospital and medical service plans, may see similar trends as companies strive to retain top talent through stock ownership incentives.

What's Next

The filing does not say what happens next.